Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2006-05-22 14:17:31 UTC |
---|
Update Date | 2023-05-30 20:55:52 UTC |
---|
HMDB ID | HMDB0002005 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Methionine sulfoxide |
---|
Description | Methionine sulfoxide (MetO) or L-Methionine sulfoxide belongs to the class of organic compounds known as L-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. Methionine sulfoxide arises through the oxidation of methionine residues in proteins by reactive oxygen species (ROS). Oxidation of methionine results in a mixture of the two diastereomers methionine-S-sulfoxide and methionine-R-sulfoxide. Methionine oxidation is considered an important post-translational event in protein synthesis and can affect the function and activity of many proteins. The oxidation of methionine plays an important role in vivo, during biological conditions of oxidative stress, as well as for protein stability in vitro. For instance, the oxidation of methionine residues in tissue proteins can cause them to misfold or otherwise render them dysfunctional. Most organisms have developed systems to restore these oxidized methionine residues back to methionine (i.e., converting MetO to Met). This reduction is done by the methionine sulfoxide reductase (MSR) system, with the MSRs type A (MSRA) and type B (MSRB) being specific for the S and R forms of MetO, respectively (PMID: 28917052 ). In mammals, the selenoprotein MSRB1 plays an important MetO repair function, and its expression is tightly regulated by dietary selenium (PMID: 28917052 ). The eventual proteolyis of any unfolded or misfolded MetO modified proteins leads to the production of free methionine sulfoxide that can be detected in blood or urine. MetO is not a proteogenic amino acid and cannot be incorporated into proteins during ribosomal mediated translation. Levels of free MetO are closely correlated with levels of oxidative stress. Methionine sulfoxide (MetO), increases with age in body tissues, and its presence is believed by some to contribute to biological aging. Levels of MetO are also increased in individuals suffering from chronic bacterial infections (tuberculosis) or other conditions causing inflammation (PMID: 32123207 ). Similarly, MetO is increased in the serum/plasma of patients diagnosed with sepsis (PMID: 27501420 ). This likely reflects the high production of ROS species arising from the overactive (but underperforming) immune response. |
---|
Structure | InChI=1S/C5H11NO3S/c1-10(9)3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-,10?/m0/s1 |
---|
Synonyms | Value | Source |
---|
L-Methionine sulfoxide | ChEBI | Methionine S-oxide | ChEBI | L-Methionine sulphoxide | Generator | Methionine sulphoxide | Generator | Methionine sulfoxide, (R-(r*,s*))-isomer | HMDB | Methionine sulfoxide, 35S-labeled, (+-)-isomer | HMDB | Methionine sulfoxide, (S-(r*,s*))-isomer | HMDB | Methionine sulfoxide, (2S)-isomer | HMDB | Methionine sulfoxide, (2R)-isomer | HMDB | Methionine sulfoxide, (+-)-isomer | HMDB | DL-Methionine sulfoxide | HMDB | L-Methionine S-oxide | HMDB | Methionine sulfoxide | HMDB |
|
---|
Chemical Formula | C5H11NO3S |
---|
Average Molecular Weight | 165.21 |
---|
Monoisotopic Molecular Weight | 165.045964392 |
---|
IUPAC Name | (2S)-2-amino-4-methanesulfinylbutanoic acid |
---|
Traditional Name | L-methionine sulfoxide |
---|
CAS Registry Number | 3226-65-1 |
---|
SMILES | CS(=O)CC[C@H](N)C(O)=O |
---|
InChI Identifier | InChI=1S/C5H11NO3S/c1-10(9)3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-,10?/m0/s1 |
---|
InChI Key | QEFRNWWLZKMPFJ-YGVKFDHGSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | L-alpha-amino acids |
---|
Alternative Parents | |
---|
Substituents | - L-alpha-amino acid
- Thia fatty acid
- Fatty acid
- Fatty acyl
- Sulfoxide
- Amino acid
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Sulfinyl compound
- Carbonyl group
- Organic oxygen compound
- Organic nitrogen compound
- Primary amine
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Amine
- Primary aliphatic amine
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 232 - 234 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Methionine sulfoxide,1TMS,isomer #1 | CS(=O)CC[C@H](N)C(=O)O[Si](C)(C)C | 1518.3 | Semi standard non polar | 33892256 | Methionine sulfoxide,1TMS,isomer #2 | CS(=O)CC[C@H](N[Si](C)(C)C)C(=O)O | 1580.5 | Semi standard non polar | 33892256 | Methionine sulfoxide,2TMS,isomer #1 | CS(=O)CC[C@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1645.4 | Semi standard non polar | 33892256 | Methionine sulfoxide,2TMS,isomer #1 | CS(=O)CC[C@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1903.5 | Standard non polar | 33892256 | Methionine sulfoxide,2TMS,isomer #1 | CS(=O)CC[C@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1942.3 | Standard polar | 33892256 | Methionine sulfoxide,2TMS,isomer #2 | CS(=O)CC[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1750.5 | Semi standard non polar | 33892256 | Methionine sulfoxide,2TMS,isomer #2 | CS(=O)CC[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1925.5 | Standard non polar | 33892256 | Methionine sulfoxide,2TMS,isomer #2 | CS(=O)CC[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 2115.4 | Standard polar | 33892256 | Methionine sulfoxide,3TMS,isomer #1 | CS(=O)CC[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1788.4 | Semi standard non polar | 33892256 | Methionine sulfoxide,3TMS,isomer #1 | CS(=O)CC[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 2078.6 | Standard non polar | 33892256 | Methionine sulfoxide,3TMS,isomer #1 | CS(=O)CC[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1834.3 | Standard polar | 33892256 | Methionine sulfoxide,1TBDMS,isomer #1 | CS(=O)CC[C@H](N)C(=O)O[Si](C)(C)C(C)(C)C | 1758.8 | Semi standard non polar | 33892256 | Methionine sulfoxide,1TBDMS,isomer #2 | CS(=O)CC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O | 1815.9 | Semi standard non polar | 33892256 | Methionine sulfoxide,2TBDMS,isomer #1 | CS(=O)CC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2082.8 | Semi standard non polar | 33892256 | Methionine sulfoxide,2TBDMS,isomer #1 | CS(=O)CC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2460.1 | Standard non polar | 33892256 | Methionine sulfoxide,2TBDMS,isomer #1 | CS(=O)CC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2135.6 | Standard polar | 33892256 | Methionine sulfoxide,2TBDMS,isomer #2 | CS(=O)CC[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2192.9 | Semi standard non polar | 33892256 | Methionine sulfoxide,2TBDMS,isomer #2 | CS(=O)CC[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2431.8 | Standard non polar | 33892256 | Methionine sulfoxide,2TBDMS,isomer #2 | CS(=O)CC[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2223.9 | Standard polar | 33892256 | Methionine sulfoxide,3TBDMS,isomer #1 | CS(=O)CC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2463.4 | Semi standard non polar | 33892256 | Methionine sulfoxide,3TBDMS,isomer #1 | CS(=O)CC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2800.8 | Standard non polar | 33892256 | Methionine sulfoxide,3TBDMS,isomer #1 | CS(=O)CC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2190.7 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Methionine sulfoxide GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (Non-derivatized) | splash10-004i-0900000000-6639ef576db5a01f8ee5 | 2019-05-22 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Methionine sulfoxide GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (Non-derivatized) | splash10-004i-0910000000-4231d540eda02eebe871 | 2019-05-22 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Methionine sulfoxide GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (Non-derivatized) | splash10-004i-0900000000-f0849e8acf9a3e1e2763 | 2019-05-22 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Methionine sulfoxide GC-MS (3 TMS) | splash10-004i-1910000000-b7a64800b9e577e219d4 | 2019-05-22 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Methionine sulfoxide GC-MS (Non-derivatized) | splash10-004i-1910000000-b7a64800b9e577e219d4 | 2019-05-22 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Methionine sulfoxide GC-EI-TOF (Non-derivatized) | splash10-004i-0900000000-a5138c4f03667c81645c | 2019-05-22 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Methionine sulfoxide GC-EI-TOF (Non-derivatized) | splash10-004i-0910000000-b8f17a35f754f6a2adff | 2019-05-22 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Methionine sulfoxide GC-EI-TOF (Non-derivatized) | splash10-004i-0900000000-40d23196cb4ee1cad23f | 2019-05-22 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Methionine sulfoxide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Methionine sulfoxide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Methionine sulfoxide Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-00di-9400000000-cac8577601b69f1b723a | 2019-05-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Methionine sulfoxide Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-00di-9000000000-43361da834d0b07907fd | 2019-05-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Methionine sulfoxide Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-00di-9000000000-6090b56aa5a22d72fb4f | 2019-05-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Methionine sulfoxide 35V, Negative-QTOF | splash10-03kc-9400000000-f71dc9c687b7114eed8b | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Methionine sulfoxide 35V, Positive-QTOF | splash10-0a4i-9100000000-b03227c3dde8ee858ffb | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Methionine sulfoxide 10V, Negative-QTOF | splash10-03di-9500000000-a4583e8c3a4365d330e2 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Methionine sulfoxide 20V, Negative-QTOF | splash10-03di-9000000000-433cb4a770ae8f69c615 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Methionine sulfoxide 40V, Negative-QTOF | splash10-0006-9000000000-ff3de228e84a6b4470bc | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Methionine sulfoxide 10V, Positive-QTOF | splash10-00di-9400000000-7375ade3d9a2e79890d4 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Methionine sulfoxide 20V, Positive-QTOF | splash10-0ab9-9000000000-4fa3654466563449190c | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Methionine sulfoxide 40V, Positive-QTOF | splash10-0a4i-9000000000-375f7404d6c31bdf96b3 | 2021-09-22 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2019-05-22 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2019-05-22 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm (predicted from logP)
|
---|
Biospecimen Locations | |
---|
Tissue Locations | |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.30-1.40 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 4.0 (3.0-5.0) uM | Adult (>18 years old) | Not Specified | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected and Quantified | 110 +/- 80 nmol/g wet feces | Adult (>18 years old) | Both | Normal | | details | Feces | Detected and Quantified | 20 +/- 10 nmol/g wet feces | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected and Quantified | 0.0444 +/- 0.0842 uM | Adult (>18 years old) | Female | Normal | | details | Saliva | Detected and Quantified | 0.110 +/- 0.126 uM | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected and Quantified | 3.28 +/- 1.20 uM | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.6418 +/- 0.4235 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Normal | | details | Urine | Detected and Quantified | 0.00-7.88 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.6-3.59 umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | Urine | Detected and Quantified | 1.48 +/- 0.80 umol/mmol creatinine | Newborn (0-30 days old) | Female | Normal | | details | Urine | Detected and Quantified | 1.67 +/- 0.69 umol/mmol creatinine | Newborn (0-30 days old) | Male | Normal | | details | Urine | Detected and Quantified | < 0.132 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.52 (0.21-0.99) umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | Urine | Detected and Quantified | 0.31 (0.14-0.66) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 2(1.4-18) uM | Adult (>18 years old) | Both | Sepsis | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal Cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Urine | Detected and Quantified | 0.5038 +/- 0.5427 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Eosinophilic esophagitis | | details | Urine | Detected and Quantified | 0.4259 +/- 0.5426 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Gastroesophageal reflux disease | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Sepsis |
---|
- Ferrario M, Cambiaghi A, Brunelli L, Giordano S, Caironi P, Guatteri L, Raimondi F, Gattinoni L, Latini R, Masson S, Ristagno G, Pastorelli R: Mortality prediction in patients with severe septic shock: a pilot study using a target metabolomics approach. Sci Rep. 2016 Feb 5;6:20391. doi: 10.1038/srep20391. [PubMed:26847922 ]
| Colorectal cancer |
---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
| Eosinophilic esophagitis |
---|
- Slae, M., Huynh, H., Wishart, D.S. (2014). Analysis of 30 normal pediatric urine samples via NMR spectroscopy (unpublished work). NA.
|
|
---|
Associated OMIM IDs | - 114500 (Colorectal cancer)
- 610247 (Eosinophilic esophagitis)
|
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB022789 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 139840 |
---|
KEGG Compound ID | C02989 |
---|
BioCyc ID | CPD0-1959 |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Methionine sulfoxide |
---|
METLIN ID | 6428 |
---|
PubChem Compound | 158980 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 17016 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Schallreuter KU: Functioning methionine-S-sulfoxide reductases A and B are present in human skin. J Invest Dermatol. 2006 May;126(5):947-9. [PubMed:16619011 ]
- O'Donohue TL, Charlton CG, Thoa NB, Helke CJ, Moody TW, Pert A, Williams A, Miller RL, Jacobowitz DM: Release of alpha-melanocyte stimulating hormone into rat and human cerebrospinal fluid in vivo and from rat hypothalamus slices in vitro. Peptides. 1981 Spring;2(1):93-100. [PubMed:7243627 ]
- Boudier C, Cadene M, Bieth JG: Inhibition of neutrophil cathepsin G by oxidized mucus proteinase inhibitor. Effect of heparin. Biochemistry. 1999 Jun 29;38(26):8451-7. [PubMed:10387091 ]
- Mashima R, Nakanishi-Ueda T, Yamamoto Y: Simultaneous determination of methionine sulfoxide and methionine in blood plasma using gas chromatography-mass spectrometry. Anal Biochem. 2003 Feb 1;313(1):28-33. [PubMed:12576054 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
- Wernly B, Lichtenauer M, Hoppe UC, Jung C: Hyperglycemia in septic patients: an essential stress survival response in all, a robust marker for risk stratification in some, to be messed with in none. J Thorac Dis. 2016 Jul;8(7):E621-4. doi: 10.21037/jtd.2016.05.24. [PubMed:27501420 ]
- Knuplez E, Marsche G: An Updated Review of Pro- and Anti-Inflammatory Properties of Plasma Lysophosphatidylcholines in the Vascular System. Int J Mol Sci. 2020 Jun 24;21(12). pii: ijms21124501. doi: 10.3390/ijms21124501. [PubMed:32599910 ]
- Tarrago L, Oheix E, Peterfi Z, Gladyshev VN: Monitoring of Methionine Sulfoxide Content and Methionine Sulfoxide Reductase Activity. Methods Mol Biol. 2018;1661:285-299. doi: 10.1007/978-1-4939-7258-6_20. [PubMed:28917052 ]
- Cho Y, Park Y, Sim B, Kim J, Lee H, Cho SN, Kang YA, Lee SG: Identification of serum biomarkers for active pulmonary tuberculosis using a targeted metabolomics approach. Sci Rep. 2020 Mar 2;10(1):3825. doi: 10.1038/s41598-020-60669-0. [PubMed:32123207 ]
|
---|